利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

215 条记录 (耗时 0.045 秒)

    Method for removing oil from water coalescing in a polymer particle/fiber media
    22.
    发明授权
    Method for removing oil from water coalescing in a polymer particle/fiber media 有权
    从聚合物颗粒/纤维介质中聚集水中的油去除油的方法

    公开(公告)号：US07297279B2

    公开(公告)日：2007-11-20

    申请号：US11042973

    申请日：2005-01-21

    申请人： Michael R. Johnson ,  John Occhipinti ,  Jerald W. Darlington, Jr.

    发明人： Michael R. Johnson ,  John Occhipinti ,  Jerald W. Darlington, Jr.

    IPC分类号： B01D17/02 ,  C02F1/28

    CPC分类号： B01D17/045 ,  B01D17/10 ,  Y10S210/05

    摘要： Apparatus in fluid communication with a water leg portion of a hydrocarbon-contaminated water, e.g., a water leg portion of a produced water stream or an offshore drilling or production platform sump tank for conveying water, separated from oil, into contact with non-woven fiber/particulate polymer coalescing media-containing canisters such that the hydrocarbon droplets and other organic material droplets commingled with the sump tank or produced water will be coalesced by passage through the coalescing media. The canisters preferably are provided in a plurality of stacks in each vessel. Solids that do not pass through the canisters are accumulated at the bottom of the vessel and easily drained through a drain port. The water and hydrocarbons will pass through the coalescing media within the canisters and will be separated easily from each vessel, e.g., by gravity separation, sot that the water can be conveyed back to the ocean water without contamination.

    摘要翻译： 与烃污染水的水腿部分流体连通的设备，例如生产水流的水腿部分或海上钻井或生产平台油底壳，用于将与油分离的水与无纺布接触 纤维/颗粒聚合物聚结介质的滤筒，使得与水槽罐或产生水混合的碳氢化合物液滴和其它有机物料液滴将通过聚结介质聚结。 罐优选地设置在每个容器中的多个堆叠中。 不通过罐的固体积聚在容器的底部并容易通过排水口排出。 水和碳氢化合物将通过罐内的聚结介质，并且将容易地从每个容器分离，例如通过重力分离，使得水可以被输送回海水而不被污染。

    Windscreen attachment for a motorcycle
    24.
    发明授权
    Windscreen attachment for a motorcycle 失效
    摩托车的挡风玻璃附件

    公开(公告)号：US07237819B2

    公开(公告)日：2007-07-03

    申请号：US11108404

    申请日：2005-04-18

    申请人： John W. Fox ,  Anthony D. Stefanelli ,  Michael R. Johnson

    发明人： John W. Fox ,  Anthony D. Stefanelli ,  Michael R. Johnson

    IPC分类号： B60J1/00

    CPC分类号： B62J17/04

    摘要： A windshield assembly for a motorcycle. The windshield assembly includes a flyscreen having one of a grommet and a coupling member and a windscreen having the other of a grommet and a coupling member. The coupling member defines a projection that engages the grommet to couple the windscreen to the flyscreen.

    摘要翻译： 摩托车的挡风玻璃总成。 挡风玻璃组件包括具有索环和联接构件之一的挡风玻璃和具有索环和联接构件中的另一个的挡风玻璃。 联接构件限定了与护环接合以将挡风玻璃联接到防尘罩的突起。

    Benzopyrans
    27.
    发明授权
    Benzopyrans 失效
    苯并吡喃

    公开(公告)号：US4841078A

    公开(公告)日：1989-06-20

    申请号：US639038

    申请日：1984-08-09

    申请人： James F. Eggler ,  Michael R. Johnson ,  Lawrence Sherman

    发明人： James F. Eggler ,  Michael R. Johnson ,  Lawrence Sherman

    IPC分类号： C07C37/055 ,  C07C39/08 ,  C07C43/23 ,  C07C61/39 ,  C07D311/22 ,  C07D311/58 ,  C07D405/12 ,  C07D407/12 ,  C07D417/12 ,  C07D491/10 ,  C07D493/06 ,  C07D493/10

    CPC分类号： C07D405/12 ,  C07C255/00 ,  C07C37/055 ,  C07C41/30 ,  C07C61/39 ,  C07D311/22 ,  C07D311/58 ,  C07D407/12 ,  C07D417/12 ,  C07D491/10 ,  C07D493/06 ,  C07D493/10

    摘要： Bicyclic fused benzenoid compounds of the formula ##STR1## and pharmaceutically acceptable cationic and acid addition salts thereof, where M is O, CH.sub.2 or NR.sub.6 ; R.sub.6 is hydrogen, formyl, carbobenzyloxy or certain carboalkoxyalkyl, alkanoyl, alkyl, aralkyl or aralkylcarbonyl groups;A' is:(1) A where one of A and B is hydrogen such that when A is hydrogen, B is C(R.sub.2 R.sub.3)(CH.sub.2).sub.f Q and f is 1 or 2; when B is hydrogen, A is C(R.sub.2 R.sub.3)(CH.sub.2).sub.f Q and f is 0 or 1, when taken together A and OR.sub.1 form a lactone or certain derivatives thereof;(2) A' is ##STR2## (3) A' is Q.sub.3 ; Q is CO.sub.2 R.sub.7, COR.sub.8, C(OH)R.sub.8 R.sub.9, CN, CONR.sub.12 R.sub.13, CH.sub.2 NR.sub.12 R.sub.13, CH.sub.2 NHCOR.sub.14, CH.sub.2 NHSO.sub.2 R.sub.17 or 5-tetrazoyl;Q.sub.3 is ##STR3## 5-tetrazolyl, CH.sub.2 CONHCOR.sub.7, COOH or certain ester, amide, carboximido or sulfonimido derivatives thereof, CONHOH, CONHCONH.sub.2, or COCH.sub.2 Q.sub.4 where Q.sub.4 is CN or COOH or certain esters thereof;R.sub.1 is hydrogen, benzyl or certain acyl groups; R.sub.4 is hydrogen, certain alkyl or certain aralkyl groups; R.sub.5 is hydrogen or certain alkyl groups; Z is (C.sub.1 -C.sub.9)alkylene, optionally interrupted by O, S, SO or SO.sub.2 ; and W is hydrogen, methyl, certain aryl or cycloalkyl groups; useful in mammals as analgesics, tranquilizers, anteimetic agents, diuretics, anticonvulsants, antidiarrheals, antitussives, in treatment of glaucoma, and intermediates therefore.

    摘要翻译： 式（I'）的双环稠合苯并噻唑类化合物及其药学上可接受的阳离子和酸加成盐，其中M为O，CH 2或NR 6; R6是氢，甲酰基，苄氧羰基或某些烷氧基烷基，烷酰基，烷基，芳烷基或芳烷基羰基; A'为：（1）其中A和B之一为氢，使得当A为氢时，B为C（R2R3）（CH2）fQ且f为1或2; 当B为氢时，A为C（R2R3）（CH2）fQ，f为0或1，当A和OR1一起形成内酯或其某些衍生物时; （2）A'是（3）A'是Q3; Q是CO 2 R 7，COR 8，C（OH）R 8 R 9，CN，CONR 12 R 13，CH 2 NR 12 R 13，CH 2 NHCOR 14，CH 2 NHSO 2 R 17或5-四唑基; Q 4是CN或COOH或其某些酯; Q 3是CN，COOH或其某些酯;其中Q 4是CN或COOH或其某些酯; R1是氢，苄基或某些酰基; R4是氢，某些烷基或某些芳烷基; R5是氢或某些烷基; Z是（C1-C9）亚烷基，任选地被O，S，SO或SO 2中断; W是氢，甲基，某些芳基或环烷基; 因此在哺乳动物中作为止痛剂，止痛剂，促炎剂，利尿剂，抗惊厥药，止泻药，镇咳药，治疗青光眼有用。

    Substituted dibenzo[b,d]pyran analgesics
    29.
    发明授权
    Substituted dibenzo[b,d]pyran analgesics 失效
    取代的二苯并[b，d]吡喃镇痛药

    公开(公告)号：US4454144A

    公开(公告)日：1984-06-12

    申请号：US390418

    申请日：1982-06-21

    申请人： Lawrence S. Melvin, Jr. ,  Michael R. Johnson

    发明人： Lawrence S. Melvin, Jr. ,  Michael R. Johnson

    IPC分类号： C07D311/80 ,  C07D405/12 ,  A61K31/35 ,  A61K31/44 ,  C07D311/78 ,  C07D405/02

    CPC分类号： C07D405/12 ,  C07D311/80

    摘要： The present invention comprises novel compounds of formula ##STR1## or a pharmaceutically acceptable salt thereof wherein: G is hydroxymethylene or carbonyl;R.sub.a and R.sub.b are each methyl or hydrogen;R.sub.1 is hydrogen or alkanoyl having one to five carbon atoms;R.sub.2 is hydrogen, bromo, chloro or fluoro;R.sub.3 is hydrogen, bromo, chloro, fluoro, alkyl having one to six carbon atoms, (CH.sub.2).sub.p COOR.sub.4 wherein p is an integer from 0-6 and R.sub.4 is hydrogen, methyl or ethyl, or (CH.sub.2).sub.q OH wherein q is an integer from 1-6; with the proviso that when R.sub.3 is hydrogen or alkyl, R.sub.2 is bromo, chloro or fluoro;Z is (--alk.sub.1).sub.m --X--(alk.sub.2).sub.n --wherein each of (alk.sub.1) and (alk.sub.2) has from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 9;m and n are each zero or 1;X is oxygen or methylene; andW is methyl, pyridyl, piperidyl or ##STR2## wherein W.sub.1 is hydrogen, fluoro, chloro or methoxy. An analgesically producing quantity of the compound when administered to a mammal produces analgesia therein.

    摘要翻译： 本发明包括式IMA的新化合物或其药学上可接受的盐，其中：G是羟基亚甲基或羰基; Ra和Rb各自为甲基或氢; R1是氢或具有1-5个碳原子的烷酰基; R2是氢，溴，氯或氟; R3是氢，溴，氯，氟，具有1-6个碳原子的烷基，（CH2）pCOOR4，其中p是0-6的整数，R4是氢，甲基或乙基，或（CH2）qOH其中q是整数 从1-6开始; 条件是当R3为氢或烷基时，R2为溴，氯或氟; Z是（-alk1）mX-（alk2）n-，其中（alk1）和（alk2）中的每一个具有1至9个碳原子，条件是（alk1）+（alk2）中的碳原子的加成不是 大于9; m和n分别为零或1; X是氧或亚甲基; W是甲基，吡啶基，哌啶基或者其中W1是氢，氟，氯或甲氧基。 给予哺乳动物的化合物的镇痛产生量在其中产生镇痛。

    9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
    30.
    发明授权
    9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics 失效

    公开(公告)号：US4351833A

    公开(公告)日：1982-09-28

    申请号：US296745

    申请日：1981-08-27

    申请人： Michael R. Johnson

    发明人： Michael R. Johnson

    IPC分类号： C07D215/22 ,  C07D215/233 ,  C07D221/12

    CPC分类号： C07D215/233 ,  C07D221/12 ,  Y10S514/85 ,  Y10S514/867 ,  Y10S514/869 ,  Y10S514/872 ,  Y10S514/906 ,  Y10S514/913

    摘要： 9-Amino-1-hydroxyoctahydrobenzo[c]quinoline derivatives of formula ##STR1## and pharmaceutically acceptable acid addition salts thereof wherein R is hydrogen, COR.sub.7 or SO.sub.2 R.sub.8 where R.sub.7 is hydrogen, alkyl, having from one to five carbon atoms; alkenyl and alkynyl each having from two to six carbon atoms; trifluoromethyl, benzyl, furyl, thienyl, pyridyl or R.sub.9 C.sub.6 H.sub.4 where R.sub.9 is H, NH.sub.2, F, Cl, Br, Ch.sub.3 or OCH.sub.3 ; R.sub.8 is alkyl having from one to five carbon atoms or R.sub.9 C.sub.6 H.sub.4 ; R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl having from one to five carbon atoms or --CO--(CH.sub.2).sub.p --NR.sub.2 R.sub.3 wherein p is 0 or an integer from 1 to 4; each of R.sub.2 and R.sub.3 when taken individually is hydrogen or alkyl having from one to four carbon atoms; R.sub.2 and R.sub.3 when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrrolo, pyrrolidino, morpholino or N-alkylpiperazino having from one to four carbon atoms in the alkyl group;R.sub.4 is hydrogen, alkyl having from 1 to 6 carbon atoms or --(CH.sub.2).sub.z --C.sub.6 H.sub.5 wherein z is an integer from 1 to 4;R.sub.5 is hydrogen, methyl or ethyl;R.sub.6 is hydrogen, --(CH.sub.2).sub.y --carbalkoxy having from one to four carbon atoms in the alkoxy group and wherein y is 0 or an integer from 1 to 4, carbobenzyloxy, formyl, alkanoyl having from two to five carbon atoms, alkyl having from one to six carbon atoms; --(CH.sub.2).sub.x --C.sub.6 H.sub.5 wherein x is an integer from 1 to 4; or --CO(CH.sub.2).sub.x-1 --C.sub.6 H.sub.5 ;Z is (a) alkylene having from one to nine carbon atoms; (b) -(alk.sub.1).sub.m --X--(alk.sub.2).sub.n -- wherein each of (alk.sub.1) and (alk.sub.2) is alkylene having from one to nine carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than nine; each of m and n is 0 or 1; X is O, S, SO and SO.sub.2 ; andW is hydrogen, methyl, pyridyl, piperidyl, ##STR2## wherein W.sub.1 is selected from the group consisting of hydrogen, fluoro and chloro; and ##STR3## wherein W.sub.2 is hydrogen or ##STR4## a is an integer from 1 to 5 and b is 0 or an integer from 1 to 5; with the proviso that the sum of a and b is not greater than 5; useful in mammals as analgesics, tranquilizers, anti-emetic agents, diuretics, anticonvulsants, antidiarrheals, antitussives, in treatment of glaucoma, and intermediates therefore.